Stimulating progress

Company

At Neuromod Devices, we are committed to stimulating progress through the design, clinical validation and commercialisation of neuromodulation technologies.

Neuromod was founded in 2010, to develop and commercialise a treatment for chronic tinnitus. We are an ISO 13485 accredited medical device manufacturer based in Dublin, Ireland and are supported by a network of long-established and internationally recognised partners.

Stimulating leadership

Leadership

Our management and board share a commitment towards achieving significant breakthroughs in the field of bimodal neuromodulation. Together, we bring our collective skills, talents and experience to bear on the pursuit of this ambitious endeavour.

Our team includes ear, nose and throat (ENT) surgeons, neuroscientists, audiologists, clinicians, engineers, regulatory experts, product designers and others who are instrumental to our vision of realising the untapped potential of neuromodulation in medicine.

Team Management

Dr. Ross O’Neill PhD MBA

Founder & CEO Linkedin

Prof. Brendan Conlon ENT

Chief Medical Officer Linkedin

Dr. Hubert Lim PhD

Chief Scientific Officer Linkedin

Florian Elsaesser

Chief Strategy & Corporate Development Officer Linkedin

Diarmuid Flavin

Chief Operating Officer Linkedin

Derek Madden CPA CTax

Chief Financial Officer Linkedin

Caroline Hamilton BSc (Aud) MSc (Neuro)

Audiology Director Linkedin

Eric Timm

President, Global Commercial Operations & Chief Executive Officer, Neuromod USA Linkedin

Stephanie Glowacki

Chief Financial Officer, Neuromod USA Linkedin

Tish Ramirez

Chief Commercial Officer, Neuromod USA Linkedin

Board of Directors

Dr. Ross O’Neill PhD MBA

Director Linkedin

Ross is a biomedical engineer with a personal passion for developing neuromodulation therapies for hearing and auditory system disorders. He founded Neuromod in 2010 to develop non-invasive neuromodulation treatments for chronic neurological disorders.

Dr. Manus Rogan PhD MBA

Chairman Linkedin

Manus is a chemist who began his career in drug development before moving into business development and venture capital investment, establishing Fountain Healthcare Partners in the 2000’s to invest in groundbreaking technologies in the life science sector.

Susan Whichard

Non-Executive Board Member Linkedin

Susan has more than 30 years’ experience in the hearing industry, having worked as both a business executive and a practicing clinical audiologist. She served as president of the Academy of Doctors of Audiology (ADA) from 1992-1994. She has also held many leadership roles at companies such as GN Resound, InSound Medical and Phonak US. More recently, Susan started a consulting business focused on start-up innovation in hearing and healthcare.

Partnership

We are proud to be working with a number of partners who share and respect our vision of this game-changing therapeutic breakthrough.

  • Investment Partners
    • Fountain Healthcare
    • Enterprise Ireland
    • Moffett Investment Holdings
    • Kreos Capital
    • Silicon Valley Bank
    • Medical Device Resources
  • Notified Body
    • BSI
  • Legal Partners
    • Byrne Wallace
  • Audit and Advisory Partners
    • KPMG
  • European Patent Attorneys
    • Tomkins
  • US Patent Attorneys
    • Shay Glenn LLP